HOME >> MEDICINE >> NEWS
PENN begins clinical trial of newest technology to treat thoracic aortic aneurysms

(Philadelphia, PA) A clinical trial is underway at the Hospital of the University of Pennsylvania (HUP) to study the safety and effectiveness of an endovascular medical device to treat life-threatening thoracic aortic aneurysms. Ronald Fairman, MD, Chief of Vascular Surgery at HUP, is leading the study at Penn and is one of 35 principal investigators in North America to participate in this landmark trial.

Thoracic aortic aneurysms (TAAs) occur when a section of the aorta the body's largest artery that carries blood out of the heart and into the organs of the body weakens and bulges outward like a balloon in the section of the artery that runs down the chest. Each year, more than 20,000 patients in the United States are diagnosed with TAA. Aortic aneurysms including thoracic and abdominal aortic aneurysms remain the 13th major cause of death in this country, accounting for nearly 15,000 deaths annually.

"The STARZ-TX2 trial is groundbreaking and excellent news for patients diagnosed with descending thoracic aortic aneurysms," says Dr. Fairman. "Surgery can be life-threatening for many of these patients and a 'wait-and-see' approach is often not an option because patients are at an increased risk of an aortic rupture. A non-surgical approach to treating this life-threatening disease could benefit thousands of lives."

The clinical trial, called STARZ-TX2 (Study of Thoracic Aortic Aneurysm Repair with the Zenith® TX2™ Thoracic TAA Endovascular Graft), is open to patients diagnosed with a descending thoracic aortic aneurysm. STARZ-TX2 will compare the outcomes of patients treated with open surgery to patients treated with the Zenith TX2 Thoracic TAA Endovascular Graft, manufactured by Cook Incorporated.

Specifically, the trial will assess device performance, as well as patient survival and aneurysm rupture rates in the surgical and endovascular treatment groups, over a 12-month period.

The trial will enroll 275 pat
'"/>

Contact: Ed Federico
ed.federico@uphs.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
16-Feb-2005


Page: 1 2

Related medicine news :

1. Hopkins begins human trials with donor adult stem cells to repair muscle damaged from heart attack
2. EuroVacc 02 HIV vaccine trial begins in February 2005
3. International trial of two microbicides begins
4. NIAID begins enrolling volunteers for novel HIV vaccine study
5. National Center for Children Exposed to Violence begins annual conference today
6. Enrollment begins for osteoarthritis initiative
7. Patients should be consulted before dialysis treatment begins
8. Clinical trial of new TB vaccine begins
9. First US tuberculosis vaccine trial in 60 years begins
10. UCSF begins study testing antiviral drug tenofovir to prevent HIV infection
11. UB begins groundbreaking study on net effect on patients of HIV treatments, other drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2019)... ... May 16, 2019 , ... Prominent pianist Paul Cardall will ... Franklin Theatre on May 22. Ballard founded O.U.R. in 2013 as the leading organization ... a former Department of Homeland Security Special Agent, leads a team of former CIA, ...
(Date:5/16/2019)... ... May 16, 2019 , ... AdventHealth West Florida Division announced ... in Tampa Bay. Today, the prestigious Leapfrog Group, a national nonprofit health care ... Only about a third of those hospitals received an “A” grade, including seven ...
(Date:5/15/2019)... ... May 16, 2019 , ... Statistical Concepts ... p.m. - 3:00 p.m. EDT, https://www.fdanews.com/statisticalconceptsprocessvalidation , Devicemakers: Are the organizations ... or even maybe … Dan O’Leary is here to help. Dan is FDAnews’s ...
(Date:5/14/2019)... ... ... in Wednesday, May 15 at 7pm for the Healthy Woman Show on WJR 760AM radio ... problems that are embarrassing and inconvenient for women. , “We know how bladder control ... time away from your home. Our goal is to help you stop leaking so ...
(Date:5/14/2019)... ... 2019 , ... The Atlanta Falcons, the Baltimore Ravens and ... the U.S. who rely on HydroWorx aquatic therapy pools to care for their ... healing,” said Timothy McCarthy, Chief Executive Officer for HydroWorx. “Whether it’s for ...
Breaking Medicine News(10 mins):
(Date:5/15/2019)... , ... May 15, 2019 , ... ... announce Gaston County’s success thanks to the Stratodesk/ViewSonic SC-T25 Citrix Ready workspace hub. ... of the joint solution in order to deliver advanced endpoint computing to their ...
(Date:5/15/2019)... ... May 15, 2019 , ... PAINWeekEnd on ... in Rhode Island, will be an educational and exciting program providing busy clinicians ... management of chronic pain. , In Rhode Island, updated regulations intended to ...
(Date:5/15/2019)... PLAINS, N.J. (PRWEB) , ... May 15, 2019 , ... ... her for. Her goal is to help patients achieve optimal dental health while addressing ... excellent care at her office in Cresskill, New Jersey. She offers both general dentistry ...
Breaking Medicine Technology:
Cached News: